Experimental Margetuximab May Help Treat Certain HER2+ Mets

Options
Moderators
Moderators Member Posts: 25,912
edited June 2019 in Stage IV/Metastatic Breast Cancer ONLY

Experimental Margetuximab May Help Treat Certain HER2-Positive Metastatic Breast Cancers
June 12, 2019
The experimental targeted therapy margetuximab combined with chemotherapy may help treat pretreated metastatic HER2-positive breast cancer in people with a specific variant of CD16A, a protein that activates immune cells. Read more...

· Share on FacebookShare on Twitter

Comments

  • MargaritaMS
    MargaritaMS Member Posts: 199
    edited June 2019

    Mods, thank you for posting this information. Hopefully, this will get the fast-track approval that it is headed for and will be another option for those of us who exhaust the usefulness of Kadcyla. It's certainly one to keep an eye on.

    Would be great to hear from someone who had this drug as part of the study... Anyone?

    · Share on FacebookShare on Twitter

Categories